Eli Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Eli Lilly and
LLY Stock  USD 844.27  26.09  3.00%   
Eli Lilly financial statements provide useful quarterly and yearly information to potential Eli Lilly and investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eli Lilly financial statements helps investors assess Eli Lilly's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eli Lilly's valuation are summarized below:
Gross Profit
36.6 B
Profit Margin
0.2351
Market Capitalization
759.3 B
Enterprise Value Revenue
17.4693
Revenue
45 B
We have found one hundred twenty available fundamental signals for Eli Lilly and, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Eli Lilly and prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 495.4 B in 2025. Enterprise Value is likely to rise to about 516.6 B in 2025

Eli Lilly Total Revenue

47.29 Billion

Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 965 M, Interest Expense of 635.7 M or Total Revenue of 47.3 B, as well as many indicators such as Price To Sales Ratio of 16.28, Dividend Yield of 0.0085 or PTB Ratio of 51.19. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
Check out the analysis of Eli Lilly Correlation against competitors.

Eli Lilly Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets77.3 B73.6 B44.2 B
Slightly volatile
Short and Long Term Debt Total30.5 B29 B13.8 B
Slightly volatile
Total Current Liabilities33 B31.4 B14.5 B
Slightly volatile
Total Stockholder Equity9.2 B14.3 B11 B
Pretty Stable
Property Plant And Equipment Net15.6 B14.9 B9.1 B
Slightly volatile
Retained Earnings9.5 B11.9 B11.7 B
Slightly volatile
Cash3.1 B3.2 B3.8 B
Pretty Stable
Cash And Short Term Investments3.7 B3.5 B4.5 B
Pretty Stable
Net Receivables13.7 B13 B6.5 B
Slightly volatile
Common Stock Shares Outstanding864.7 M904.1 M1 B
Slightly volatile
Liabilities And Stockholders Equity77.3 B73.6 B44.2 B
Slightly volatile
Inventory7 B6.6 B3.8 B
Slightly volatile
Other Current Assets6.9 B6.5 B2.4 B
Slightly volatile
Total Current Assets3.3 B3.5 B13.9 B
Pretty Stable
Intangible Assets8.3 B7.9 B5 B
Slightly volatile
Other Current Liabilities16.8 B16 B7 B
Slightly volatile
Short Term Debt8.3 B7.9 B2.5 B
Slightly volatile
Accounts Payable3.1 B3 B1.6 B
Slightly volatile
Property Plant And Equipment Gross29 B27.6 B12.9 B
Slightly volatile
Short Term Investments93.3 M98.2 M611.7 M
Slightly volatile
Capital Stock544.7 M534.2 M644 M
Slightly volatile
Common Stock544.7 M534.2 M644 M
Slightly volatile
Other Liabilities5.5 B7 B6.7 B
Slightly volatile
Long Term Debt22.1 B21.1 B11.4 B
Slightly volatile
Property Plant Equipment8.5 B11.7 B8.5 B
Slightly volatile
Good Will2.9 B5.7 B3.1 B
Slightly volatile
Current Deferred Revenue17.5 B16.7 B7.7 B
Slightly volatile
Long Term Debt Total11.6 B16.9 B10.6 B
Slightly volatile
Capital Surpluse6.6 B8 B6.1 B
Slightly volatile
Long Term Investments2.9 B2.7 B3.7 B
Slightly volatile
Non Current Liabilities Other1.9 B2 B5 B
Slightly volatile
Short and Long Term Debt8.3 B7.9 B2.2 B
Slightly volatile
Cash And Equivalents3.5 B1.9 B4.1 B
Slightly volatile
Net Invested Capital27.8 B41.4 B26.4 B
Slightly volatile
Capital Lease Obligations389.4 M438 M477.6 M
Slightly volatile

Eli Lilly Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization965 M1.7 B1.4 B
Slightly volatile
Total Revenue47.3 B45 B25.5 B
Slightly volatile
Gross Profit38.5 B36.6 B19.9 B
Slightly volatile
Other Operating Expenses33.8 B32.1 B19 B
Slightly volatile
Operating Income13.5 B12.9 B5.9 B
Slightly volatile
EBIT17.9 B17 B6.5 B
Slightly volatile
EBITDA19.7 B18.7 B7.9 B
Slightly volatile
Cost Of Revenue8.8 B8.4 B5.7 B
Slightly volatile
Total Operating Expenses24.9 B23.7 B13.3 B
Slightly volatile
Income Before Tax13.3 B12.7 B5.7 B
Slightly volatile
Income Tax Expense2.2 B2.1 B1 B
Slightly volatile
Selling General Administrative5.7 B8 B6.4 B
Pretty Stable
Research Development15 B14.3 B6.6 B
Slightly volatile
Non Recurring267.2 M281.3 M690.7 M
Very volatile
Selling And Marketing Expenses394.9 M415.7 M4.5 B
Slightly volatile
Minority Interest241.8 M211.1 M162.6 M
Slightly volatile
Tax Provision989.6 M1.5 B781.6 M
Slightly volatile
Interest Income204.8 M199.6 M153.2 M
Slightly volatile
Reconciled Depreciation1.6 B1.8 B1.5 B
Very volatile

Eli Lilly Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.3 B2.8 B4.1 B
Pretty Stable
Depreciation1 B1.8 B1.4 B
Slightly volatile
Dividends Paid4.9 B4.7 B2.7 B
Slightly volatile
Total Cash From Operating Activities4.3 B4.9 B5.1 B
Pretty Stable
End Period Cash Flow3.4 B3.2 B3.9 B
Very volatile
Issuance Of Capital Stock1.3 B1.5 B1.6 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio16.2815.56.8547
Slightly volatile
Dividend Yield0.00850.00890.0221
Slightly volatile
PTB Ratio51.1948.75220.7084
Slightly volatile
Days Sales Outstanding61.9410986.0054
Slightly volatile
Book Value Per Share16.6315.835311.4343
Pretty Stable
Operating Cash Flow Per Share2.994.244.9748
Slightly volatile
Stock Based Compensation To Revenue0.01450.02120.013
Slightly volatile
Capex To Depreciation5.845.572.069
Slightly volatile
PB Ratio51.1948.75220.7084
Slightly volatile
EV To Sales16.2815.57.1055
Slightly volatile
Inventory Turnover1.831.411.6036
Slightly volatile
Days Of Inventory On Hand180268232
Slightly volatile
Payables Turnover3.012.453.8397
Slightly volatile
Sales General And Administrative To Revenue0.320.230.2799
Slightly volatile
Research And Ddevelopement To Revenue0.170.31680.2362
Slightly volatile
Capex To Revenue0.260.250.1104
Slightly volatile
Cash Per Share2.562.934.2561
Pretty Stable
POCF Ratio11711139.387
Slightly volatile
Interest Coverage24.8821.306621.6865
Slightly volatile
Capex To Operating Cash Flow1.651.570.589
Slightly volatile
Days Payables Outstanding12415499.2428
Slightly volatile
EV To Operating Cash Flow12211641.2538
Slightly volatile
Intangibles To Total Assets0.110.170.1692
Slightly volatile
Current Ratio1.61.081.3736
Slightly volatile
Receivables Turnover5.413.464.4315
Slightly volatile
Graham Number67.8264.592532.8166
Slightly volatile
Shareholders Equity Per Share16.6315.835311.3111
Pretty Stable
Debt To Equity2.212.111.5243
Slightly volatile
Capex Per Share7.777.42.8038
Slightly volatile
Revenue Per Share52.349.806426.2643
Slightly volatile
Interest Debt Per Share0.640.669410.5514
Slightly volatile
Debt To Assets0.180.350.2611
Slightly volatile
Enterprise Value Over EBITDA36.7837.237223.7909
Slightly volatile
Short Term Coverage Ratios0.530.55106
Pretty Stable
Operating Cycle242377318
Slightly volatile
Price Book Value Ratio51.1948.75220.7084
Slightly volatile
Days Of Payables Outstanding12415499.2428
Slightly volatile
Price To Operating Cash Flows Ratio11711139.387
Slightly volatile
Pretax Profit Margin0.250.28150.2117
Pretty Stable
Ebt Per Ebit1.010.98310.9883
Slightly volatile
Operating Profit Margin0.280.28640.2207
Slightly volatile
Effective Tax Rate0.30.16490.2409
Pretty Stable
Company Equity Multiplier5.625.354.6736
Slightly volatile
Long Term Debt To Capitalization0.60.570.4608
Slightly volatile
Total Debt To Capitalization0.660.630.4974
Slightly volatile
Return On Capital Employed0.250.320.1925
Slightly volatile
Debt Equity Ratio2.212.111.5243
Slightly volatile
Ebit Per Revenue0.280.28640.2207
Slightly volatile
Quick Ratio0.90.661.0267
Slightly volatile
Dividend Paid And Capex Coverage Ratio0.40.431.1663
Slightly volatile
Cash Ratio0.08830.09290.3365
Slightly volatile
Cash Conversion Cycle161256228
Pretty Stable
Operating Cash Flow Sales Ratio0.280.140.2282
Pretty Stable
Days Of Inventory Outstanding180268232
Slightly volatile
Days Of Sales Outstanding61.9410986.0054
Slightly volatile
Cash Flow Coverage Ratios0.180.190.629
Slightly volatile
Price To Book Ratio51.1948.75220.7084
Slightly volatile
Fixed Asset Turnover1.842.382.6514
Slightly volatile
Capital Expenditure Coverage Ratio0.490.522.807
Slightly volatile
Price Cash Flow Ratio11711139.387
Slightly volatile
Enterprise Value Multiple36.7837.237223.7909
Slightly volatile
Debt Ratio0.180.350.2611
Slightly volatile
Cash Flow To Debt Ratio0.180.190.629
Slightly volatile
Price Sales Ratio16.2815.56.8547
Slightly volatile
Asset Turnover0.70.610.5993
Slightly volatile
Gross Profit Margin0.620.81310.756
Very volatile
Price Fair Value51.1948.75220.7084
Slightly volatile

Eli Lilly Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap495.4 B471.8 B228 B
Slightly volatile
Enterprise Value516.6 B492 B239.7 B
Slightly volatile

Eli Fundamental Market Drivers

Forward Price Earnings37.037
Cash And Short Term Investments3.5 B

Eli Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue16.7 B17.5 B
Total Revenue45 B47.3 B
Cost Of Revenue8.4 B8.8 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.23  0.32 
Research And Ddevelopement To Revenue 0.32  0.17 
Capex To Revenue 0.25  0.26 
Revenue Per Share 49.81  52.30 
Ebit Per Revenue 0.29  0.28 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CSXCSX Corporation
ETONEton Pharmaceuticals
ALLTAllot Communications

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY